El Hassanne Larhrib

Senior Lecturer, Department of Pharmacy
School of Applied Sciences
Member, Pharmaceutics and Drug Delivery Centre
Associate Member, Microbial Therapeutics and Infection Control Centre
Associate Member, Biorefinery Engineering and Bioprocessing Research Centre

https://orcid.org/0000-0002-8655-7250

Phone01484 473051
EmailE.Larhrib@hud.ac.uk
Websitehttps://research.hud.ac.uk

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where El Hassanne Larhrib is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

7 Similar Profiles

Dry Powder Inhalers Medicine & Life Sciences

Inhalation Medicine & Life Sciences

Lactose Medicine & Life Sciences

Albuterol Medicine & Life Sciences

Tablets Medicine & Life Sciences

Powders Chemical Compounds

Sulfates Medicine & Life Sciences

Pharmaceutical Preparations Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1995 2020

24 Article

The effect of inspiratory parameters after two separate inhalations on the dose emission of theophylline from low and high resistance dry powder inhalers

Abadelah, M., Al-Assadi, J., Rooney, J. & Larhrib, E. H., 1 Jan 2020, In : Saudi Pharmaceutical Journal. 28, 1, p. 74-86 13 p.

Research output: Contribution to journal › Article

Open Access

Dry Powder Inhalers

Theophylline

Powders

Inhalation

Lactose

Real-life budesonide and formoterol dose emission from the medium and high strength fixed dosed combinations in a Spiromax® dry powder inhaler using inhalation profiles from patients with chronic obstructive pulmonary disease

Bagherisadeghi, G., Chrystyn, H., Abadelah, M. & Larhrib, E., 1 Nov 2019, In : European Journal of Pharmaceutical Sciences. 139, 10 p., 105059.

Research output: Contribution to journal › Article

Dry Powder Inhalers

Budesonide

Chronic Obstructive Pulmonary Disease

Inhalation

Formoterol Fumarate

Use of inspiratory profiles from patients with chronic obstructive pulmonary disease (COPD) to investigate drug delivery uniformity and aerodynamic dose emission of indacaterol from a capsule based dry powder inhaler

Abadelah, M., Chrystyn, H. & Larhrib, E., 15 Jun 2019, In : European Journal of Pharmaceutical Sciences. 134, p. 138-144 7 p.

Research output: Contribution to journal › Article

Dry Powder Inhalers

Chronic Obstructive Pulmonary Disease

Inhalation

Capsules

Pharmaceutical Preparations

5 Citations (Scopus)

Study of the Emitted Dose After Two Separate Inhalations at Different Inhalation Flow Rates and Volumes and an Assessment of Aerodynamic Characteristics of Indacaterol Onbrez Breezhaler®150 and 300 μg

Abadelah, M., Chrystyn, H., Bagherisadeghi, G., Abdalla, G. & Larhrib, H., 1 Jan 2018, In : AAPS PharmSciTech. 19, 1, p. 251-261 11 p.

Research output: Contribution to journal › Article

Open Access

aerodynamics

Inhalation

breathing

dosage

strength (mechanics)

10 Citations (Scopus)

Effect of maximum inhalation flow and inhaled volume on formoterol drug deposition in-vitro from an Easyhaler® dry powder inhaler

Abadelah, M., Hazim, F., Chrystyn, H., Bagherisadeghi, G., Rahmoune, H. & Larhrib, H., 15 Jun 2017, In : European Journal of Pharmaceutical Sciences. 104, p. 180-187 8 p.

Research output: Contribution to journal › Article

Dry Powder Inhalers

Inhalation

Pharmaceutical Preparations

Formoterol Fumarate

In Vitro Techniques

Activities 2018 2018

1 Invited talk

Digital Two-way Inhalation/Exhalation Profile Recorder for Airway Disease Self-Training and Management to Help Patients Achieve Optimal Inhalation Manoeuvre Parameters for Efficient Lung Delivery of Inhaled Medicines

El Larhrib (Speaker), Mahmoud Dhimish (Contributor to Paper or Presentation)

25 Apr 2018

Activity: Talk or presentation types › Invited talk